[Quality of life of patients with chronic hepatitis C: effect of treatments].
Couzigou
Patrice
P
Service d'Hépato-Gastroentérologie, USN, Hôpital Haut-Lévêque, Pessac.
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D011594:Psychometrics; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D013997:Time Factors; D019562:Viral Load
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons